JP2020536931A5 - - Google Patents
Info
- Publication number
- JP2020536931A5 JP2020536931A5 JP2020520646A JP2020520646A JP2020536931A5 JP 2020536931 A5 JP2020536931 A5 JP 2020536931A5 JP 2020520646 A JP2020520646 A JP 2020520646A JP 2020520646 A JP2020520646 A JP 2020520646A JP 2020536931 A5 JP2020536931 A5 JP 2020536931A5
- Authority
- JP
- Japan
- Prior art keywords
- layer
- dolutegravir
- tablet
- lamivudine
- crystalline cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120922A JP2025165977A (ja) | 2017-10-13 | 2025-07-18 | 二層医薬錠剤製剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762571863P | 2017-10-13 | 2017-10-13 | |
| US62/571,863 | 2017-10-13 | ||
| US201862634317P | 2018-02-23 | 2018-02-23 | |
| US62/634,317 | 2018-02-23 | ||
| PCT/US2018/054825 WO2019074826A2 (en) | 2017-10-13 | 2018-10-08 | FORMULATION OF BICOLET PHARMACEUTICAL TABLET |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120922A Division JP2025165977A (ja) | 2017-10-13 | 2025-07-18 | 二層医薬錠剤製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020536931A JP2020536931A (ja) | 2020-12-17 |
| JP2020536931A5 true JP2020536931A5 (enExample) | 2025-09-11 |
| JP7774958B2 JP7774958B2 (ja) | 2025-11-25 |
Family
ID=66101717
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020520646A Active JP7774958B2 (ja) | 2017-10-13 | 2018-10-08 | 二層医薬錠剤製剤 |
| JP2025120922A Pending JP2025165977A (ja) | 2017-10-13 | 2025-07-18 | 二層医薬錠剤製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120922A Pending JP2025165977A (ja) | 2017-10-13 | 2025-07-18 | 二層医薬錠剤製剤 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20200230141A1 (enExample) |
| EP (2) | EP3694522B1 (enExample) |
| JP (2) | JP7774958B2 (enExample) |
| KR (2) | KR20200070246A (enExample) |
| CN (2) | CN111246851A (enExample) |
| AU (1) | AU2018347990B2 (enExample) |
| BR (1) | BR112020006783A2 (enExample) |
| CA (1) | CA3078624A1 (enExample) |
| CL (1) | CL2020000959A1 (enExample) |
| ES (1) | ES3056013T3 (enExample) |
| FI (1) | FI3694522T3 (enExample) |
| IL (1) | IL273704B2 (enExample) |
| MX (1) | MX2020003377A (enExample) |
| PL (1) | PL3694522T3 (enExample) |
| PT (1) | PT3694522T (enExample) |
| TW (1) | TWI841539B (enExample) |
| WO (1) | WO2019074826A2 (enExample) |
| ZA (1) | ZA202002263B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022519290A (ja) * | 2019-02-05 | 2022-03-22 | ヴィーブ ヘルスケア カンパニー | ドルテグラビル及びラミブジンでｈｉｖを治療する方法 |
| WO2021116244A1 (en) * | 2019-12-12 | 2021-06-17 | Sandoz Ag | Modulation of drug release and bioavailability of compositions containing dolutegravir sodium and other anti hiv drugs |
| CN111991558B (zh) * | 2020-08-28 | 2022-08-09 | 安徽贝克生物制药有限公司 | 一种抗逆转录病毒药物组合物及其制备方法 |
| CN114191404B (zh) * | 2022-01-10 | 2023-06-27 | 安徽贝克生物制药有限公司 | 一种多替拉韦片剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101733625B1 (ko) | 2008-12-11 | 2017-05-10 | 시오노기세야쿠 가부시키가이샤 | 카르바모일피리돈 ｈｉｖ 인테그라제 억제제 및 중간체의 합성 |
| US9713622B2 (en) * | 2009-11-20 | 2017-07-25 | Université Versailles Saint-Quentin-En-Yvelines | Schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (HIV) |
| LT3494972T (lt) * | 2010-01-27 | 2024-03-12 | Viiv Healthcare Company | Dolutegraviro ir lamivudino kompozicija živ infekcijai gydyti |
| US20170189402A1 (en) * | 2012-03-28 | 2017-07-06 | Abbvie Inc. | Solid dosage forms |
| AU2013336491B2 (en) * | 2012-10-23 | 2018-08-02 | Cipla Limited | Pharmaceutical antiretroviral composition |
| IN2013MU01749A (enExample) | 2013-05-15 | 2015-06-26 | Cipla Ltd | |
| WO2016016279A1 (en) * | 2014-07-29 | 2016-02-04 | Lek Pharmaceuticals D.D. | Novel hydrates of dolutegravir sodium |
| CN106860464A (zh) * | 2017-02-16 | 2017-06-20 | 江苏艾迪药业有限公司 | 用于联合抗病毒治疗的药物组合物及应用 |
-
2018
- 2018-10-08 EP EP18866268.8A patent/EP3694522B1/en active Active
- 2018-10-08 CN CN201880066314.8A patent/CN111246851A/zh active Pending
- 2018-10-08 US US16/652,768 patent/US20200230141A1/en active Pending
- 2018-10-08 PT PT188662688T patent/PT3694522T/pt unknown
- 2018-10-08 BR BR112020006783-0A patent/BR112020006783A2/pt unknown
- 2018-10-08 JP JP2020520646A patent/JP7774958B2/ja active Active
- 2018-10-08 PL PL18866268.8T patent/PL3694522T3/pl unknown
- 2018-10-08 AU AU2018347990A patent/AU2018347990B2/en active Active
- 2018-10-08 CN CN202311269854.5A patent/CN117281788A/zh active Pending
- 2018-10-08 EP EP25212183.5A patent/EP4667003A3/en active Pending
- 2018-10-08 MX MX2020003377A patent/MX2020003377A/es unknown
- 2018-10-08 FI FIEP18866268.8T patent/FI3694522T3/fi active
- 2018-10-08 KR KR1020207010456A patent/KR20200070246A/ko not_active Ceased
- 2018-10-08 KR KR1020247041200A patent/KR20250004136A/ko active Pending
- 2018-10-08 IL IL273704A patent/IL273704B2/en unknown
- 2018-10-08 CA CA3078624A patent/CA3078624A1/en active Pending
- 2018-10-08 WO PCT/US2018/054825 patent/WO2019074826A2/en not_active Ceased
- 2018-10-08 ES ES18866268T patent/ES3056013T3/es active Active
- 2018-10-11 TW TW107135747A patent/TWI841539B/zh active
-
2020
- 2020-04-09 CL CL2020000959A patent/CL2020000959A1/es unknown
- 2020-05-04 ZA ZA2020/02263A patent/ZA202002263B/en unknown
-
2025
- 2025-07-18 JP JP2025120922A patent/JP2025165977A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH10147517A (ja) | 高められた崩壊特性を有するフイルムコーテイングされた錠剤組成物 | |
| JP2020536931A5 (enExample) | ||
| JP7336388B2 (ja) | 錠剤及びその製造方法 | |
| HU186078B (en) | Process for producing pharmaceutical compositions for peroral application containing dipyridamol | |
| JP7472540B2 (ja) | 固形組成物 | |
| WO2012156981A1 (en) | Pharmaceutical compositions of lurasidone | |
| EA024699B1 (ru) | Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат | |
| CA2903283C (en) | Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof | |
| JPS6241646B2 (enExample) | ||
| CN105407925A (zh) | 用于泡腾剂型的制造工艺 | |
| JP2017043546A (ja) | 感冒用医薬組成物 | |
| HU228823B1 (en) | Swallowable tablets with high content of n-acetylcysteine | |
| WO2009084041A4 (en) | Pharmaceutical compositions of dexibuprofen | |
| JP4185974B2 (ja) | カリウム、ナトリウムおよびトリスオキサプロジン塩医薬組成物 | |
| JP6758488B2 (ja) | カンデサルタンおよびアムロジピンを含む単一層からなる複合製剤 | |
| WO2023168295A1 (en) | Therapeutic compounds, formulations, and use thereof | |
| RU2580656C1 (ru) | Твердая лекарственная форма гидроксихлорохина немедленного высвобождения и способ ее получения | |
| JP5625262B2 (ja) | 固形製剤 | |
| WO2006134610A1 (en) | Efavirenz pharmaceutical composition having enhanced dissolution profile | |
| US20130035344A1 (en) | Pharmaceutical composition for oral administration | |
| JP4719899B2 (ja) | 口腔内速崩壊性錠剤 | |
| RU2281773C1 (ru) | Лекарственная форма, обладающая антибактериальным воздействием, и способ ее изготовления | |
| JP6963281B2 (ja) | イブプロフェン含有錠剤 | |
| KR101428149B1 (ko) | 이매티닙메실산염 함유 과립, 이를 포함하는 경구용 속방성 정제 조성물 및 그것의 제조방법 | |
| JP7014406B2 (ja) | ロキソプロフェン含有錠剤およびその製造方法 |